Agents against cytokine synthesis or receptors

Toshiyuki Yamagata, Masakazu Ichinose

Research output: Contribution to journalReview articlepeer-review

46 Citations (Scopus)

Abstract

Various cytokines play a critical role in pathophysiology of chronic inflammatory lung diseases including asthma and chronic obstructive pulmonary disease (COPD). The increasing evidence of the involvement of these cytokines in the development of airway inflammation raises the possibility that these cytokines may become the novel promising therapeutic targets. Studies concerning the inhibition of interleukin (IL)-4 have been discontinued despite promising early results in asthma. Although blocking antibody against IL-5 markedly reduces the infiltration of eosinophils in peripheral blood and airway, it does not seem to be effective in symptomatic asthma, while blocking IL-13 might be more effective. On the contrary, anti-inflammatory cytokines themselves such as IL-10, IL-12, IL-18, IL-23 and interferon-γ may have a therapeutic potential. Inhibition of TNF-α may also be useful in severe asthma or COPD. Many chemokines are also involved in the inflammatory response of asthma and COPD through the recruitment of inflammatory cells. Several small molecule inhibitors of chemokine receptors are now in development for the treatment of asthma and COPD. Antibodies that block IL-8 reduce neutrophilic inflammation. Chemokine CC3 receptor antagonists, which block eosinophil chemotaxis, are now in clinical development for asthma therapy. As many cytokines are involved in the pathophysiology of inflammatory lung diseases, inhibitory agents of the synthesis of multiple cytokines may be more useful tools. Several such agents are now in clinical development.

Original languageEnglish
Pages (from-to)289-301
Number of pages13
JournalEuropean Journal of Pharmacology
Volume533
Issue number1-3
DOIs
Publication statusPublished - 2006 Mar 8
Externally publishedYes

Keywords

  • Asthma
  • Chemokine
  • Chemokine receptor
  • Chronic obstructive pulmonary disease
  • Cytokine

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Agents against cytokine synthesis or receptors'. Together they form a unique fingerprint.

Cite this